Koninklijke DSM NV (DSMN.AS)
DSMN.AS on Amsterdam Stock Exchange
100.35EUR
24 May 2019
100.35EUR
24 May 2019
Change (% chg)
€0.47 (+0.47%)
€0.47 (+0.47%)
Prev Close
€99.88
€99.88
Open
€100.00
€100.00
Day's High
€101.35
€101.35
Day's Low
€99.88
€99.88
Volume
664,652
664,652
Avg. Vol
724,968
724,968
52-wk High
€105.30
€105.30
52-wk Low
€68.00
€68.00
About
Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company's segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties. Its Performance... (more)
Overall
| Beta: | 0.83 |
| Market Cap(Mil.): | €12,599.97 |
| Shares Outstanding(Mil.): | 181.43 |
| Dividend: | 0.58 |
| Yield (%): | 2.56 |
Financials
| DSMN.AS | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 16.53 | 15.43 | 313.16 |
| EPS (TTM): | 4.20 | -- | -- |
| ROI: | 5.62 | 7.25 | 11.39 |
| ROE: | 13.12 | 11.40 | 14.37 |
DSM sets up vitamin E joint venture with China's Nenter
AMSTERDAM DSM NV, the Dutch nutrition company, said on Tuesday it would set up a joint venture with Chinese biochemicals company Nenter & Co. to manufacture vitamin E, paying Nenter 135 million euros ($154.45 million) to acquire its facilities in China.
DSM sets up vitamin E joint venture with China's Nenter
AMSTERDAM, Jan 29 DSM NV, the Dutch nutrition company, said on Tuesday it would set up a joint venture with Chinese biochemicals company Nenter & Co. to manufacture vitamin E, paying Nenter 135 million euros ($154.45 million) to acquire its facilities in China.
Estimates